What is translational cancer pathology?
Translational cancer pathology is using tissue from a patient with cancer to study the molecular mechanisms of cancer, then translating these basic scientific discoveries into a personalised medicine approach.
The main aim of our research is to better understand the determinants of short- and long-term outcomes in patients with colorectal cancer.
We are interested in the relationship between local and systemic inflammatory responses, tumour microenvironment, and cell signalling, with a view to taking such knowledge into the routine clinical management of colorectal cancer.
Our overarching aim is to develop novel treatment strategies to establish a personalised medicine approach for colorectal cancer.
We would like to acknowledge the generous support of our funders, past and present:
